Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw

The aim of this study is to analyze surgical and functional outcomes in order to verify the applicability of surgical treatment guidelines as foreseen by MASCC/ISOO/ASCO 2019. Patients affected by stage 2 MRONJ refractory to conservative management were grouped if underwent surgical resection (Group...

Full description

Bibliographic Details
Main Authors:	Salvatore D’Amato, Antonio Troiano, Giorgio Lo Giudice, Davide De Cicco, Mario Rusciano, Gianpaolo Tartaro, Giuseppe Colella
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	Applied Sciences
Subjects:	MRONJ medication-related osteonecrosis of the jaw BRONJ debridement resective surgery
Online Access:	https://www.mdpi.com/2076-3417/11/18/8553

Similar Items

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
by: Mario Migliario, et al.
Published: (2017-03-01)

Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis
by: Falk Wehrhan, et al.
Published: (2019-03-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
by: Christian Bacci, et al.
Published: (2021-01-01)

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
by: Gioacchino Catania, et al.
Published: (2016-12-01)

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) in cancer patients
by: A K Ebzeev
Published: (2020-04-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Medication-related osteonecrosis of the jaw treatment modalities: A review
by: Amir Ali Asadi
Published: (2020-08-01)

BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016-01-01)

Clinical diagnosis and treatment on bisphosphonate⁃related osteonecrosis of the jaw
by: YIN Xue⁃min, et al.
Published: (2017-03-01)

Osteonecrosis of the jaw after dental implant placement. A case report
by: J.L. Calvo-Guirado, et al.
Published: (2014-03-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Treatment of Biphosphonate-Related Osteonecrosis of the Jaw (BRONJ) Combining Surgical Resection and PRGF-Endoret® and Rehabilitation with Dental Implants: Case Report
by: Anitua Eduardo
Published: (2017-03-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Medication-Related Osteonecrosis of the Jaws Initiated by Zoledronic Acid and Potential Pathophysiology
by: Aya Alsalih, et al.
Published: (2021-07-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Johannes Laimer, et al.
Published: (2021-05-01)

Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report
by: Manzon L, et al.
Published: (2014-08-01)

Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw
by: Siri Paulo, et al.
Published: (2020-04-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
by: Shin-Yu Lu, et al.
Published: (2021-11-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

Choosing the Right Partner for Medication Related Osteonecrosis of the Jaw: What Central European Dentists Know
by: Emanuel Bruckmoser, et al.
Published: (2021-04-01)

Effect of bacterial infection on bone quality and structure in osteonecrosis of the jaw by bisphosphonate (BP) administration
by: Matsunaga, S., et al.
Published: (2021)

New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures
by: Johannes Laimer, et al.
Published: (2021-04-01)

Osteomyelitis of the mandible exhibiting features of medication-related osteonecrosis in a patient with history of tocilizumab treatment
by: Mohammed A Bindakhil, et al.
Published: (2018-01-01)

Evaluation of medication-related osteonecrosis of the jaw using the Japanese Adverse Drug Event Report database
by: Inada A, et al.
Published: (2018-12-01)

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study
by: Karapinar Gökay, et al.
Published: (2021-03-01)

Spontaneous Osteogenic Potential of Periosteum after Segmental Mandibulectomy in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 14 Cases
by: Fang, Y.-Q, et al.
Published: (2023)

Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience
by: Betul Taş Ozyurtseven, et al.
Published: (2021-05-01)

The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes
by: Amerigo Giudice, et al.
Published: (2020-11-01)

Medication-related osteonecrosis of the jaw: A review about etiology, risk factors, pathophysiology, and treatment
by: Sheetal Singar, et al.
Published: (2020-01-01)

Experience of pain in a patient with BRONJ
by: Bakal O, et al.
Published: (2015-07-01)

MRONJ and VIT D insufficiency
by: Gholamreza Shirani, et al.
Published: (2021-07-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)